StonvexLoading…
StonvexCore line items from SMHI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $46.51M | $44.28M | $227.83M | $175.50M | $116.31M |
Operating Income | Not available | $-6.38M | $13.72M | $18.88M | $814.00K |
Net Income | Not available | $-15.80M | $-27.84M | $-13.22M | $-22.22M |
EPS (Diluted) | $-1.26 | $-0.61 | $-1.06 | $-0.50 | $-0.83 |
Total Assets | Not available | $640.75M | $660.60M | $692.50M | $680.03M |
Total Liabilities | Not available | $392.91M | $395.93M | $414.83M | $412.23M |
Cash & Equivalents | Not available | $38.72M | $68.93M | $90.95M | $34.38M |
Free Cash Flow OCF − CapEx | Not available | $-21.22M | $-85.18M | $-64.56M | $-44.55M |
Shares Outstanding | Not available | 25.78M | 26.22M | 26.41M | 26.79M |